Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency

about

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

Item

http://www.wikidata.org/entity/Q58124906

description

im Juni 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2012

@uk

name

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@en

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@nl

type

Item

label

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@en

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@nl

prefLabel

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@en

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@nl

P1476

Serum amyloid A (SAA), inflammation, cholesterol and mevalonate kinase deficiency – reply

@en

P2093

Robert Kisilevsky

http://www.w3.org/2001/XMLSchema#string

P2860

Acute-phase serum amyloid A: perspectives on its physiological and pathological roles

Impact of serum amyloid A on high density lipoprotein composition and levels.

ATP binding cassette G1-dependent cholesterol efflux during inflammation.

The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.

Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.

Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency.

Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency.

The path of murine serum amyloid a through peritoneal macrophages

P304

165-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506129.2012.702703

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

inflammation